Overview

An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
An extension study of linifanib in subjects with advanced or metastatic solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Abbott
AbbVie